Jonathan Keats, PhD 🇨🇦
@pedalheadphx.bsky.social
480 followers
830 following
290 posts
🇨🇦 boiling in the Arizona desert and not riding my bikes enough. Cancer researcher focused on multiple myeloma and clinical genomics at TGen, part of City of Hope. Creator of MyelomaSky and Sequencing Tech feeds. Director, Collaborative Sequencing Center
Posts
Media
Videos
Starter Packs
Pinned
Reposted by Jonathan Keats, PhD 🇨🇦
Reposted by Jonathan Keats, PhD 🇨🇦
Nature
@nature.com
· 18d
In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma - Nature
In vivo loss-of-function CRISPR screens were performed to identify genes influencing CAR T cell persistence and function in human multiple myeloma, highlighting CDKN1B as a promising target.
go.nature.com
Reposted by Jonathan Keats, PhD 🇨🇦
Lukas Hatscher
@loggas.bsky.social
· Sep 13
Highly multiplexed imaging recovers immune and metabolic niches in multiple myeloma associated with disease progression and bone involvement
Multiple myeloma (MM) is a cancer arising from genetically aberrant plasma cells (PCs) that remain dependent on the bone marrow (BM) microenvironment for disease establishment and progression. Here, w...
www.biorxiv.org
Reposted by Jonathan Keats, PhD 🇨🇦
Reposted by Jonathan Keats, PhD 🇨🇦
Reposted by Jonathan Keats, PhD 🇨🇦
Reposted by Jonathan Keats, PhD 🇨🇦
Reposted by Jonathan Keats, PhD 🇨🇦
PLMcCarthyBuffalo
@plmbuffalo.bsky.social
· Jul 31
New prognostic systems for multiple myeloma in the context of contemporary therapies
Recent clinical trials in both transplant eligible and ineligible newly diagnosed multiple myeloma utilising three and four drug combinations have demonstr
ashpublications.org
Reposted by Jonathan Keats, PhD 🇨🇦
Reposted by Jonathan Keats, PhD 🇨🇦